Gan & Lee Pharmaceuticals Plans RMB 814M Private Placement for Working Capital
China-based Gan & Lee Pharmaceuticals (SHA: 603087) has announced plans to raise up to RMB...
Rongsheng Bio Set for IPO on STAR Board to Boost Vaccine R&D
Shanghai Rongsheng Biotech Co., Ltd is preparing to conduct an initial public offering (IPO) of...
Daiichi Sankyo Initiates Global Phase II Study of DS7300 for Small-Cell Lung Cancer
Japan-based Daiichi Sankyo Inc. (TYO: 4568) has announced the first patient dosing in a global...
Abbisko’s ABSK021 Gets CDE Approval for Phase III Study in Giant Cell Tumor of Tendon Sheath
Shanghai-based biotech Abbisko Therapeutics Co., Ltd (HKG: 2256) has announced that it has received approval...
Livzon Launches National Rollout of COVID-19 Vaccine V-01 in China
China-based Livzon Pharmaceutical Group (HKG: 1513) has announced the national promotion of its recombinant novel...
Venmedtech Raises Series B+ Funding for Iliac Vein Stent and Product R&D
Venmedtech, a Suzhou-based one-stop intravenous therapy product platform, has reportedly raised “tens of millions” of...
Celgenyx Completes RMB 100M Series A Financing for Next-Gen Cell Therapy Development
China-based Hangzhou Celgenyx Gene Technology Co., Ltd has announced the completion of a Series A...
Easy-Flow Medical Secures Angel Funding for Peripheral Device Development
China-based peripheral interventional device manufacturer Shanghai Easy-Flow Medical Tech Co., Ltd has reportedly raised “tens...
Hengrui Medicine Gains Approval for Phase Ib/II Study of SHR-A1811 and SHR-1701 in HER2-Positive Gastric Cancer
China-based Jiangsu Hengrui Medicine Co., Ltd (SHA: 600276) has announced receiving approval to initiate a...
Zhejiang Pushkang Biotech Raises RMB 100M in Series C+ Financing
China-based Zhejiang Pushkang Biotechnology Co., Ltd, a leading centrifugal microfluidic platform company, has reportedly raised...
Sinovac Partners with Colombia University to Boost Vaccine R&D
China’s Sinovac (NASDAQ: SVA) has announced a partnership with Universidad de Antioquia of Colombia (UdeA)...
SeeNeuro Medical Raises RMB 100M in Series B Funding for Neural Regulation Devices
Hangzhou-based SeeNeuro Medical, a developer of implantable neural regulation devices, has reportedly raised RMB 100...
MicuRx Pharmaceuticals Concludes US Phase I Study for MRX-8
Shanghai-based antibacterial drug developer MicuRx Pharmaceuticals (SHA: 688373) has announced the conclusion of Phase I...
Henlius Biotech’s Hanbeitai Approved for Hepatocellular Carcinoma
Shanghai Henlius Biotech Inc. (HKG: 2696) has announced receiving a fourth indication approval from the...
Antengene’s Xpovio Receives Taiwan FDA Approval for Multiple Indications
China-based biopharma Antengene Corp., Ltd (HKG: 6996) has announced receiving market approval from the Taiwan...
AIM Vaccine Receives CDE Approval for Serum-Free Rabies Vaccine Trial
China-based AIM Vaccine Co., Ltd (HKG: 6660) has announced receiving clinical trial approval from the...
Rici Healthcare to Acquire Unicorn II Holdings for RMB 180M
China-based Rici Healthcare Holdings Limited (HKG: 1526), also known as Rich Healthcare, is set to...
Roche Reports Q3 Sales Growth, Hit by COVID-19 Product Decline
Swiss pharmaceutical giant Roche (SWX: ROG) released its Q3 2022 financial report last week, showing...
Ambrx Biopharma Halts Development of HER2 ADC ARX788, Cuts Workforce
US-based, China-owned biotech Ambrx Biopharma Inc. (NYSE: AMAM) has announced plans to end the development...
Sinopharm’s Wuhan Institute Isolates Monkeypox Strains, Begins Vaccine Research
China’s Wuhan Institute of Biological Products, a research affiliate of Sinopharm’s China National Biotech Group...